Skip to main content
. Author manuscript; available in PMC: 2018 Oct 5.
Published in final edited form as: Leukemia. 2018 Mar 22;32(10):2250–2262. doi: 10.1038/s41375-018-0104-2

Fig. 3. Verification of the binding between MALAT1 and PARP1 by RIP-PCR.

Fig. 3

(A) Schematic diagram of the RIP-PCR assay. (B) The level of PARP1 before or after RIP was determined by immunoblotting. (C) MALAT1 pulled-down by PARP1 antibody-conjugated beads were determined by qRT-PCR (right panel), left panel is input (*p<0.05, **p<0.01, ***p<0.001).